PANCREATIC CARCINOMA STAGE II

PANCREATIC CARCINOMA STAGE II was reported 640 times

These drug classes are most commonly taken by patients reporting PANCREATIC CARCINOMA STAGE II:

# Drug Count
0 GLP-1 Receptor Agonist [EPC] 7
1 Corticosteroid [EPC] 4
2 Insulin Analog [EPC] 4
3 Proton Pump Inhibitor [EPC] 4
4 Benzodiazepine [EPC] 3
5 HMG-CoA Reductase Inhibitor [EPC] 3
6 Provitamin D2 Compound [EPC] 3
7 Factor Xa Inhibitor [EPC] 2
8 Histamine-2 Receptor Antagonist [EPC] 2
9 Interleukin-23 Antagonist [EPC] 2
10 Loop Diuretic [EPC] 2
11 Microtubule Inhibitor [EPC] 2
12 Opioid Agonist [EPC] 2
13 Thalidomide Analog [EPC] 2
14 Aldosterone Antagonist [EPC] 1
15 Calcium Channel Blocker [EPC] 1
16 Central Nervous System Stimulant [EPC] 1
17 Dihydropyridine Calcium Channel Blocker [EPC] 1
18 Expectorant [EPC] 1
19 Fluoroquinolone Antibacterial [EPC] 1
20 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1
21 Hepatitis C Virus NS5A Inhibitor [EPC] 1
22 Integrin Receptor Antagonist [EPC] 1
23 Interferon beta [EPC] 1
24 Interleukin-17A Antagonist [EPC] 1
25 Leukocyte Growth Factor [EPC] 1
26 Leukotriene Receptor Antagonist [EPC] 1
27 Methylxanthine [EPC] 1
28 Osmotic Laxative [EPC] 1
29 PCSK9 Inhibitor [EPC] 1
30 Potassium Salt [EPC] 1
31 Potassium-sparing Diuretic [EPC] 1
32 Prostaglandin Analog [EPC] 1
33 Serotonin-3 Receptor Antagonist [EPC] 1
34 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
35 Sulfonylurea [EPC] 1
36 Thrombopoietin Receptor Agonist [EPC] 1
37 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
38 Xanthine Oxidase Inhibitor [EPC] 1
39 alpha-Glucosidase Inhibitor [EPC] 1